Koefisien utang jangka dawa marang modal Progyny Corp (PGNY)

Simbol lan logo merek Progyny, Inc. (PGNY)

This daily price chart for Progyny, Inc. (PGNY) illustrates the asset's dynamics, with a value of 0.05. The business relies on a network of partner medical centers and proprietary treatment methodologies that increase switching costs for clients. B2B contracts with major US firms to provide IVF services for employees generate the company's revenue. Progyny, Inc. (PGNY) is currently scaling its IT platform in an effort to secure government contracts and expand its range of available medical procedures.

PGNY Progyny: Utang jangka dawa marang modal ing interval 04.07.2022 - 01.11.2026
Produk dadi Progyny

Progyny, Inc. (PGNY) maintains a dominant position in the corporate outsourcing segment and vendor independence, allowing the company to effectively manage its debt load. By analyzing the long-term capital structure, an investor assesses the proportion of liabilities with maturities exceeding one year relative to equity, which determines the level of financial leverage and the overall resilience of the business's market value to external credit risks.

Analisis perusahaan pesaing

HCA (HCA Holdings) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Tenet (THC)|FMS (Fresenius Medical) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Kewajiban jangka dawa marang modal|Universal Health Services Corp - Utang jangka dawa marang modal|DVA - Utang jangka dawa marang modal|RDNT (RadNet Corp) - Rasio utang jangka dawa marang ekuitas|OPCH: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Surgery Partners, Inc.|Rasio utang jangka dawa marang ekuitas premierinc.com (PINC)|Utang jangka dawa marang modal EYE|ARDT - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Select Medical Corp SEM|ASTH: Rasio utang jangka dawa marang modal|MD: Rasio utang jangka dawa marang ekuitas|U.S. Physical Therapy - Rasio silihan jangka dawa marang modal|The Pennant Group (PNTG) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas ORGO (Organogenesis Holdings Inc.)|Utang jangka dawa marang ekuitas Nutex Health Corp|AUNA: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas SBC Medical Group (SBC)|EOLS - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal CYH (Community Health Systems, Inc.)|Tanggungan utang jangka dawa marang ekuitas The Beauty Health Company|MDWD: Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Biote Corporation|The Joint Corp. (JYNT) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal DCGO|Rasio utang jangka dawa marang ekuitas PIII|Kewajiban jangka dawa marang modal Gain Therapeutics Inc. GANX|Rasio utang jangka dawa marang ekuitas EUDA (EUDA Health)|BMGL (baselmedical.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal CLGN (CollPlant Biotechnologies Ltd.)|Rasio tanggungan utang jangka dawa marang modal cuprina.com.sg (CUPR)|CCM - Utang jangka dawa marang ekuitas|AMS (American Shared Hospital Services Inc) - Rasio utang jangka dawa marang modal|MRM: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Avalon GloboCare Corp.|Rasio utang jangka dawa marang ekuitas DHAI|carmellcosmetics.com (XAGE) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NewGenIvf (NIVF)|ATIP: Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal CMAX (CareMax Medical Group)|Tanggungan utang jangka dawa marang ekuitas Kindly Health|MODV - Utang jangka dawa marang ekuitas|NVOS (novointegrated.com) - Rasio utang jangka dawa marang modal|SSY (sunlinkhealth.com) - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal IMAC Holdings Inc (BACK)